Biomedical Research | Novartis

Story
Nov 21, 2024
Addressing unmet needs for inherited neuromuscular diseases
Story
May 31, 2024
A legacy of blood cancer innovation
Story
May 27, 2024
A personal journey full circle, from curiosity about life on Earth to transformative therapies at Novartis
Story
Feb 08, 2024
How collaboration can enhance your science career
Media Release
Sep 01, 2022
Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis
Story
Nov 01, 2022
A scientist from the start – Q&A with NIBR President Fiona Marshall
Story
Nov 18, 2021
The art of drug design in a technological age
Story
Nov 12, 2021
Stopping this coronavirus – and the next one
Media Release
Oct 28, 2020
Novartis announces collaboration with Molecular Partners to develop two DARPin® therapies designed for potential use against COVID-19
Media Release
May 03, 2021
Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine
Story
Jun 08, 2016
The future of chronic myeloid leukemia is evolving
Story
Mar 22, 2017
Striving to vanquish leukemia